-
Personalizing Lung Cancer Treatment Reduces Toxicity and Improves Cure Rates
08 May 2025 14:25 GMT
… population.3
New lung cancer treatment options have … NSCLC. Chemotherapy-free lung cancer treatment would be … effective.
Advancing Personalized Lung Cancer Treatment
Chemotherapy can cause … cetuximab for unresectable stage III non-small-cell lung cancer. …
-
Functionalized Boron Carbide Nanoparticles as Active Boron Delivery Agents Dedicated to Boron Neutron Capture Therapy
24 May 2025 00:50 GMT
… Additionally, in mice with lung cancer and pulmonary metastases, slowing … anti-EGFR monoclonal antibody cetuximab was effectively delivered … 106 cells to A549 lung cancer cells.35
The obtained … Capture Therapy in the lung cancer treatment. Nanomedicine. 2015 …
-
ASCO 2025: The Presentations That May Shift the Cancer Care Paradigm
23 May 2025 18:30 GMT
… frontline encorafenib (Braftovi) plus cetuximab (Erbitux) and modified fluorouracil, leucovorin … include non–small cell lung cancer (NSCLC) and melanoma … to encorafenib with cetuximab and mFOLFOX6 for … metastatic non-small cell lung cancer (NSCLC) or cutaneous …
-
NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
20 Mar 2025 20:15 GMT
… NBTXR3) for patients with lung cancer (NSCLC) to be … presented at the 2025 European Lung Cancer Conference (“ELCC”). ABSTRACT … Locoregional Recurrent Non-Small Cell Lung Cancer (“NSCLC”)
Saumil J. … therapy, with or without cetuximab, for the treatment …
-
Boehringer Ingelheim Showcases Bold Vision For The Future Of Cancer Care At ASCO 2025
22 May 2025 23:03 GMT
… PD-1 inhibitor ezabenlimab and cetuximab in patients (pts) … About non-small cell lung cancer (NSCLC)
Lung cancer claims more lives … Up to 4% of lung cancers are driven by HER2 … cell lung cancer: current treatment and future advances, Transl Lung Cancer Res. …
-
Lilly Announces Details Of Presentations At 2025 American Society Of Clinical Oncology (ASCO) Annual Meeting
22 May 2025 23:03 GMT
… small cell lung cancer (NSCLC) and in combination with cetuximab in patients … KRAS G12C inhibitor, plus cetuximab in KRAS G12C-mutant … .m. CDT
Session Title: Lung Cancer – Non-Small Cell Metastatic
… patients with non-small cell lung cancer (NSCLC), and 1-3% …
-
Bristol Myers Squibb to Present Data at ASCO® 2025 Highlighting Differentiated Research Platform of Oncology Treatments and Innovative Research Pipeline
22 May 2025 21:28 GMT
… Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC) … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816-neoadjuvant non-small cell lung cancer, … KRAZATI in combination with cetuximab is indicated for the …
-
Design, Synthesis and Evaluation of Novel Cyclopropanesulfonamide Derivatives for the Treatment of EGFRC797S Mutation in Non-Small Cell Lung Cancer
27 Feb 2025 05:59 GMT
… cell lung cancer (NSCLC) and small cell lung cancer.1,2 … was combined with cetuximab,26 it demonstrated inhibitory … G, Pelosi E. Lung cancers: molecular characterization, clonal heterogeneity … non-small cell lung cancer (NSCLC). Lung Cancer. 2019;137:113 …
-
Metastatic Colorectal Cancer Pipeline Appears Robust With 150+ Key Pharma Companies Actively Working In The Therapeutics Segment | Delveinsight
22 May 2025 04:37 GMT
… in combination with cetuximab for the treatment … , NV1020, MRTX849, Pembrolizumab, Cetuximab, erlotinib, FOLFOX, and others … recurrent non-small cell lung cancer (NSCLC) and … , NV1020, MRTX849, Pembrolizumab, Cetuximab, erlotinib, FOLFOX , and others …
-
Frontline Fulzerasib Plus Cetuximab Elicits Deep, Durable Responses in KRAS G12C–Mutated NSCLC
28 Mar 2025 13:33 GMT
… fulzerasib (GFH925) and cetuximab (Erbitux) demonstrated efficacy with acceptable … advanced non–small cell lung cancer (NSCLC) harboring KRAS … during the 2025 European Lung Cancer Congress.1
At a … Presented at: 2025 European Lung Cancer Congress; March 26-29 …
About
© 1995-2025